ALLUZIENCE 200 units Speywood/ml, solution for injection 2 bottles of 0.625 ml
Active ingredients: TOXINE BOTULINIQUE TYPE A
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 bottles of 0.625 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALLUZIENCE 200 unités Speywood/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 2 flacon(s) en verre de 0,625 ml
- Marketing authorisation holder
- IPSEN PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 13 Oct 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- For professional use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69497348CIP73023277CIP133400930232774Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOXINE BOTULINIQUE TYPE Asolution | 200 unités Speywood · un flacon de 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.